Galectin Therapeutics Inc
GALT· Nasdaq
GALTGalectin Therapeutics Inc
Filed Mar 29, 2018 · 10-K · 88 days after period end · 0001193125-18-100592
derived · Computed from the longer spans the company filed.
| Metric | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures | Q4 2015 | Q4 2014 |
|---|---|---|---|---|
| Net Income | -$2.38M | -$4.59M | -$4.67M | -$3.73M |
| EPS Diluted | — | — | -$0.19 | -$0.17 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Galectin Therapeutics Inc · CIK 1133416 · Engraved from SEC EDGAR
ended Dec 31, 2017 · filed Mar 29, 2018 · 88 d after period end
